IGHV Mutation Status and Outcome in CLL Patients Treated with Chemoimmunotherapy: A Nationwide Analysis

Emelie Curovic Rotbain; Caspar da Cunha-Bang; H. Hjalgrim; K. Rostgaard; M. A. Andersen; Henrik Frederiksen; CU Niemann; CU Niemann

IGHV Mutation Status and Outcome in CLL Patients Treated with Chemoimmunotherapy: A Nationwide Analysis

Emelie Curovic Rotbain, Caspar da Cunha-Bang, H. Hjalgrim, K. Rostgaard, M. A. Andersen, Henrik Frederiksen, CU Niemann, CU Niemann

KI, Hæmatologi

Publikation: Konferencebidrag uden forlag/tidsskrift › Poster › Forskning › peer review

Originalsprog	Engelsk
Publikationsdato	dec. 2017
Status	Udgivet - dec. 2017
Begivenhed	59th Annual Meeting and Exposition of the American Society of Hematology December 9-12th 2017, Atlanta, USA   - Atlanta, USA Varighed: 9. dec. 2017 → 12. dec. 2017

Konference

Konference	59th Annual Meeting and Exposition of the American Society of Hematology December 9-12th 2017, Atlanta, USA
Land	USA
By	Atlanta
Periode	09/12/2017 → 12/12/2017

Dokumenter og links

https://ash.confex.com/ash/2017/webprogram/Paper99903.html

Citationsformater

Curovic Rotbain, E., da Cunha-Bang, C., Hjalgrim, H., Rostgaard, K., Andersen, M. A., Frederiksen, H., Niemann, CU., & Niemann, CU. (2017). IGHV Mutation Status and Outcome in CLL Patients Treated with Chemoimmunotherapy: A Nationwide Analysis. Poster session præsenteret på 59th Annual Meeting and Exposition of the American Society of Hematology December 9-12th 2017, Atlanta, USA   , Atlanta, USA. https://ash.confex.com/ash/2017/webprogram/Paper99903.html

Curovic Rotbain, Emelie ; da Cunha-Bang, Caspar ; Hjalgrim, H. ; Rostgaard, K. ; Andersen, M. A. ; Frederiksen, Henrik ; Niemann, CU ; Niemann, CU. / IGHV Mutation Status and Outcome in CLL Patients Treated with Chemoimmunotherapy: A Nationwide Analysis. Poster session præsenteret på 59th Annual Meeting and Exposition of the American Society of Hematology December 9-12th 2017, Atlanta, USA   , Atlanta, USA.

@conference{90aaa46897714f1f8d77ae6164a90182,

title = "IGHV Mutation Status and Outcome in CLL Patients Treated with Chemoimmunotherapy: A Nationwide Analysis",

author = "{Curovic Rotbain}, Emelie and {da Cunha-Bang}, Caspar and H. Hjalgrim and K. Rostgaard and Andersen, {M. A.} and Henrik Frederiksen and CU Niemann and CU Niemann",

year = "2017",

month = dec,

language = "English",

note = "null ; Conference date: 09-12-2017 Through 12-12-2017",

}

Curovic Rotbain, E, da Cunha-Bang, C, Hjalgrim, H, Rostgaard, K, Andersen, MA, Frederiksen, H, Niemann, CU & Niemann, CU 2017, 'IGHV Mutation Status and Outcome in CLL Patients Treated with Chemoimmunotherapy: A Nationwide Analysis', 59th Annual Meeting and Exposition of the American Society of Hematology December 9-12th 2017, Atlanta, USA   , Atlanta, USA, 09/12/2017 - 12/12/2017. <https://ash.confex.com/ash/2017/webprogram/Paper99903.html>

IGHV Mutation Status and Outcome in CLL Patients Treated with Chemoimmunotherapy: A Nationwide Analysis. / Curovic Rotbain, Emelie; da Cunha-Bang, Caspar; Hjalgrim, H.; Rostgaard, K.; Andersen, M. A.; Frederiksen, Henrik; Niemann, CU; Niemann, CU.

2017. Poster session præsenteret på 59th Annual Meeting and Exposition of the American Society of Hematology December 9-12th 2017, Atlanta, USA   , Atlanta, USA.

Publikation: Konferencebidrag uden forlag/tidsskrift › Poster › Forskning › peer review

TY - CONF

T1 - IGHV Mutation Status and Outcome in CLL Patients Treated with Chemoimmunotherapy: A Nationwide Analysis

AU - Curovic Rotbain, Emelie

AU - da Cunha-Bang, Caspar

AU - Hjalgrim, H.

AU - Rostgaard, K.

AU - Andersen, M. A.

AU - Frederiksen, Henrik

AU - Niemann, CU

PY - 2017/12

Y1 - 2017/12

M3 - Poster

Y2 - 9 December 2017 through 12 December 2017

ER -